Global Human Papillomavirus Protein E6 Market Insights and Forecast to 2026

世界のヒトパピローマウイルスタンパク質E6市場2026:インサイト・予測

◆タイトル:Global Human Papillomavirus Protein E6 Market Insights and Forecast to 2026
◆商品コード:QYR20NV01430
◆調査・発行会社:QYResearch
◆発行日:2020年11月
◆ページ数:111
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥405,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥608,400見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートはヒトパピローマウイルスタンパク質E6の世界市場について調査・分析した資料です。種類別(ABN-301、BVAC-C、ETBX-041、GX-188E、その他)の市場規模、用途別(子宮頸部上皮内腫瘍、肺がん、中咽頭がん、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ヒトパピローマウイルスタンパク質E6の競争状況、市場シェア
・世界のヒトパピローマウイルスタンパク質E6市場:種類別市場規模 2015年-2020年(ABN-301、BVAC-C、ETBX-041、GX-188E、その他)
・世界のヒトパピローマウイルスタンパク質E6市場:種類別市場規模予測 2021年-2026年(ABN-301、BVAC-C、ETBX-041、GX-188E、その他)
・世界のヒトパピローマウイルスタンパク質E6市場:用途別市場規模 2015年-2020年(子宮頸部上皮内腫瘍、肺がん、中咽頭がん、その他)
・世界のヒトパピローマウイルスタンパク質E6市場:用途別市場規模予測 2021年-2026年(子宮頸部上皮内腫瘍、肺がん、中咽頭がん、その他)
・北米のヒトパピローマウイルスタンパク質E6市場分析:米国、カナダ
・ヨーロッパのヒトパピローマウイルスタンパク質E6市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのヒトパピローマウイルスタンパク質E6市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のヒトパピローマウイルスタンパク質E6市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのヒトパピローマウイルスタンパク質E6市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Rottapharm Biotech Srl、Selecta Biosciences Inc、Transgene SA、Abion Inc、BioNTech AG、Cancer Research Technology Ltd、Etubics Corp、Genexine Inc、Hookipa Biotech AG、Inovio Pharmaceuticals Inc、MedImmune LLC
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Human Papillomavirus Protein E6 Market
The global Human Papillomavirus Protein E6 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Human Papillomavirus Protein E6 Scope and Market Size
Human Papillomavirus Protein E6 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Papillomavirus Protein E6 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Human Papillomavirus Protein E6 market is segmented into
ABN-301
BVAC-C
ETBX-041
GX-188E
Others

Segment by Application, the Human Papillomavirus Protein E6 market is segmented into
Cervical Intraepithelial Neoplasia
Lung Cancer
Oropharyngeal Cancer
Others

Regional and Country-level Analysis
The Human Papillomavirus Protein E6 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Papillomavirus Protein E6 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Papillomavirus Protein E6 Market Share Analysis
Human Papillomavirus Protein E6 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Papillomavirus Protein E6 business, the date to enter into the Human Papillomavirus Protein E6 market, Human Papillomavirus Protein E6 product introduction, recent developments, etc.

The major vendors covered:
Rottapharm Biotech Srl
Selecta Biosciences Inc
Transgene SA
Abion Inc
BioNTech AG
Cancer Research Technology Ltd
Etubics Corp
Genexine Inc
Hookipa Biotech AG
Inovio Pharmaceuticals Inc
MedImmune LLC

【レポートの目次】

1 Study Coverage
1.1 Human Papillomavirus Protein E6 Product Introduction
1.2 Market Segments
1.3 Key Human Papillomavirus Protein E6 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Papillomavirus Protein E6 Market Size Growth Rate by Type
1.4.2 ABN-301
1.4.3 BVAC-C
1.4.4 ETBX-041
1.4.5 GX-188E
1.4.6 Others
1.5 Market by Application
1.5.1 Global Human Papillomavirus Protein E6 Market Size Growth Rate by Application
1.5.2 Cervical Intraepithelial Neoplasia
1.5.3 Lung Cancer
1.5.4 Oropharyngeal Cancer
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Human Papillomavirus Protein E6 Market Size, Estimates and Forecasts
2.1.1 Global Human Papillomavirus Protein E6 Revenue 2015-2026
2.1.2 Global Human Papillomavirus Protein E6 Sales 2015-2026
2.2 Global Human Papillomavirus Protein E6, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Papillomavirus Protein E6 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Papillomavirus Protein E6 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Human Papillomavirus Protein E6 Competitor Landscape by Players
3.1 Human Papillomavirus Protein E6 Sales by Manufacturers
3.1.1 Human Papillomavirus Protein E6 Sales by Manufacturers (2015-2020)
3.1.2 Human Papillomavirus Protein E6 Sales Market Share by Manufacturers (2015-2020)
3.2 Human Papillomavirus Protein E6 Revenue by Manufacturers
3.2.1 Human Papillomavirus Protein E6 Revenue by Manufacturers (2015-2020)
3.2.2 Human Papillomavirus Protein E6 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Papillomavirus Protein E6 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Papillomavirus Protein E6 Revenue in 2019
3.2.5 Global Human Papillomavirus Protein E6 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Papillomavirus Protein E6 Price by Manufacturers
3.4 Human Papillomavirus Protein E6 Manufacturing Base Distribution, Product Types
3.4.1 Human Papillomavirus Protein E6 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Papillomavirus Protein E6 Product Type
3.4.3 Date of International Manufacturers Enter into Human Papillomavirus Protein E6 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Human Papillomavirus Protein E6 Market Size by Type (2015-2020)
4.1.1 Global Human Papillomavirus Protein E6 Sales by Type (2015-2020)
4.1.2 Global Human Papillomavirus Protein E6 Revenue by Type (2015-2020)
4.1.3 Human Papillomavirus Protein E6 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Papillomavirus Protein E6 Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Papillomavirus Protein E6 Sales Forecast by Type (2021-2026)
4.2.2 Global Human Papillomavirus Protein E6 Revenue Forecast by Type (2021-2026)
4.2.3 Human Papillomavirus Protein E6 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Papillomavirus Protein E6 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Human Papillomavirus Protein E6 Market Size by Application (2015-2020)
5.1.1 Global Human Papillomavirus Protein E6 Sales by Application (2015-2020)
5.1.2 Global Human Papillomavirus Protein E6 Revenue by Application (2015-2020)
5.1.3 Human Papillomavirus Protein E6 Price by Application (2015-2020)
5.2 Human Papillomavirus Protein E6 Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Papillomavirus Protein E6 Sales Forecast by Application (2021-2026)
5.2.2 Global Human Papillomavirus Protein E6 Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Papillomavirus Protein E6 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Human Papillomavirus Protein E6 by Country
6.1.1 North America Human Papillomavirus Protein E6 Sales by Country
6.1.2 North America Human Papillomavirus Protein E6 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Papillomavirus Protein E6 Market Facts & Figures by Type
6.3 North America Human Papillomavirus Protein E6 Market Facts & Figures by Application

7 Europe
7.1 Europe Human Papillomavirus Protein E6 by Country
7.1.1 Europe Human Papillomavirus Protein E6 Sales by Country
7.1.2 Europe Human Papillomavirus Protein E6 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Papillomavirus Protein E6 Market Facts & Figures by Type
7.3 Europe Human Papillomavirus Protein E6 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Human Papillomavirus Protein E6 by Region
8.1.1 Asia Pacific Human Papillomavirus Protein E6 Sales by Region
8.1.2 Asia Pacific Human Papillomavirus Protein E6 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Papillomavirus Protein E6 Market Facts & Figures by Type
8.3 Asia Pacific Human Papillomavirus Protein E6 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Human Papillomavirus Protein E6 by Country
9.1.1 Latin America Human Papillomavirus Protein E6 Sales by Country
9.1.2 Latin America Human Papillomavirus Protein E6 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Papillomavirus Protein E6 Market Facts & Figures by Type
9.3 Central & South America Human Papillomavirus Protein E6 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Human Papillomavirus Protein E6 by Country
10.1.1 Middle East and Africa Human Papillomavirus Protein E6 Sales by Country
10.1.2 Middle East and Africa Human Papillomavirus Protein E6 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Papillomavirus Protein E6 Market Facts & Figures by Type
10.3 Middle East and Africa Human Papillomavirus Protein E6 Market Facts & Figures by Application

11 Company Profiles
11.1 Rottapharm Biotech Srl
11.1.1 Rottapharm Biotech Srl Corporation Information
11.1.2 Rottapharm Biotech Srl Description and Business Overview
11.1.3 Rottapharm Biotech Srl Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Rottapharm Biotech Srl Human Papillomavirus Protein E6 Products Offered
11.1.5 Rottapharm Biotech Srl Related Developments
11.2 Selecta Biosciences Inc
11.2.1 Selecta Biosciences Inc Corporation Information
11.2.2 Selecta Biosciences Inc Description and Business Overview
11.2.3 Selecta Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Selecta Biosciences Inc Human Papillomavirus Protein E6 Products Offered
11.2.5 Selecta Biosciences Inc Related Developments
11.3 Transgene SA
11.3.1 Transgene SA Corporation Information
11.3.2 Transgene SA Description and Business Overview
11.3.3 Transgene SA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Transgene SA Human Papillomavirus Protein E6 Products Offered
11.3.5 Transgene SA Related Developments
11.4 Abion Inc
11.4.1 Abion Inc Corporation Information
11.4.2 Abion Inc Description and Business Overview
11.4.3 Abion Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abion Inc Human Papillomavirus Protein E6 Products Offered
11.4.5 Abion Inc Related Developments
11.5 BioNTech AG
11.5.1 BioNTech AG Corporation Information
11.5.2 BioNTech AG Description and Business Overview
11.5.3 BioNTech AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 BioNTech AG Human Papillomavirus Protein E6 Products Offered
11.5.5 BioNTech AG Related Developments
11.6 Cancer Research Technology Ltd
11.6.1 Cancer Research Technology Ltd Corporation Information
11.6.2 Cancer Research Technology Ltd Description and Business Overview
11.6.3 Cancer Research Technology Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Cancer Research Technology Ltd Human Papillomavirus Protein E6 Products Offered
11.6.5 Cancer Research Technology Ltd Related Developments
11.7 Etubics Corp
11.7.1 Etubics Corp Corporation Information
11.7.2 Etubics Corp Description and Business Overview
11.7.3 Etubics Corp Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Etubics Corp Human Papillomavirus Protein E6 Products Offered
11.7.5 Etubics Corp Related Developments
11.8 Genexine Inc
11.8.1 Genexine Inc Corporation Information
11.8.2 Genexine Inc Description and Business Overview
11.8.3 Genexine Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Genexine Inc Human Papillomavirus Protein E6 Products Offered
11.8.5 Genexine Inc Related Developments
11.9 Hookipa Biotech AG
11.9.1 Hookipa Biotech AG Corporation Information
11.9.2 Hookipa Biotech AG Description and Business Overview
11.9.3 Hookipa Biotech AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hookipa Biotech AG Human Papillomavirus Protein E6 Products Offered
11.9.5 Hookipa Biotech AG Related Developments
11.10 Inovio Pharmaceuticals Inc
11.10.1 Inovio Pharmaceuticals Inc Corporation Information
11.10.2 Inovio Pharmaceuticals Inc Description and Business Overview
11.10.3 Inovio Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E6 Products Offered
11.10.5 Inovio Pharmaceuticals Inc Related Developments
11.1 Rottapharm Biotech Srl
11.1.1 Rottapharm Biotech Srl Corporation Information
11.1.2 Rottapharm Biotech Srl Description and Business Overview
11.1.3 Rottapharm Biotech Srl Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Rottapharm Biotech Srl Human Papillomavirus Protein E6 Products Offered
11.1.5 Rottapharm Biotech Srl Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Papillomavirus Protein E6 Market Estimates and Projections by Region
12.1.1 Global Human Papillomavirus Protein E6 Sales Forecast by Regions 2021-2026
12.1.2 Global Human Papillomavirus Protein E6 Revenue Forecast by Regions 2021-2026
12.2 North America Human Papillomavirus Protein E6 Market Size Forecast (2021-2026)
12.2.1 North America: Human Papillomavirus Protein E6 Sales Forecast (2021-2026)
12.2.2 North America: Human Papillomavirus Protein E6 Revenue Forecast (2021-2026)
12.2.3 North America: Human Papillomavirus Protein E6 Market Size Forecast by Country (2021-2026)
12.3 Europe Human Papillomavirus Protein E6 Market Size Forecast (2021-2026)
12.3.1 Europe: Human Papillomavirus Protein E6 Sales Forecast (2021-2026)
12.3.2 Europe: Human Papillomavirus Protein E6 Revenue Forecast (2021-2026)
12.3.3 Europe: Human Papillomavirus Protein E6 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Papillomavirus Protein E6 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Papillomavirus Protein E6 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Papillomavirus Protein E6 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Papillomavirus Protein E6 Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Papillomavirus Protein E6 Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Papillomavirus Protein E6 Sales Forecast (2021-2026)
12.5.2 Latin America: Human Papillomavirus Protein E6 Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Papillomavirus Protein E6 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Papillomavirus Protein E6 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Papillomavirus Protein E6 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Papillomavirus Protein E6 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Papillomavirus Protein E6 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Papillomavirus Protein E6 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Papillomavirus Protein E6 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Human Papillomavirus Protein E6 Market Segments
Table 2. Ranking of Global Top Human Papillomavirus Protein E6 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Papillomavirus Protein E6 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ABN-301
Table 5. Major Manufacturers of BVAC-C
Table 6. Major Manufacturers of ETBX-041
Table 7. Major Manufacturers of GX-188E
Table 8. Major Manufacturers of Others
Table 9. Global Human Papillomavirus Protein E6 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Human Papillomavirus Protein E6 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Human Papillomavirus Protein E6 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Human Papillomavirus Protein E6 Sales Market Share by Regions (2015-2020)
Table 13. Global Human Papillomavirus Protein E6 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Human Papillomavirus Protein E6 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Human Papillomavirus Protein E6 Sales Share by Manufacturers (2015-2020)
Table 16. Global Human Papillomavirus Protein E6 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Human Papillomavirus Protein E6 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus Protein E6 as of 2019)
Table 18. Human Papillomavirus Protein E6 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Human Papillomavirus Protein E6 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Human Papillomavirus Protein E6 Price (2015-2020) (USD/Pcs)
Table 21. Human Papillomavirus Protein E6 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Papillomavirus Protein E6 Product Type
Table 23. Date of International Manufacturers Enter into Human Papillomavirus Protein E6 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Papillomavirus Protein E6 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Human Papillomavirus Protein E6 Sales Share by Type (2015-2020)
Table 27. Global Human Papillomavirus Protein E6 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Human Papillomavirus Protein E6 Revenue Share by Type (2015-2020)
Table 29. Human Papillomavirus Protein E6 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Human Papillomavirus Protein E6 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Human Papillomavirus Protein E6 Sales Share by Application (2015-2020)
Table 32. North America Human Papillomavirus Protein E6 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Human Papillomavirus Protein E6 Sales Market Share by Country (2015-2020)
Table 34. North America Human Papillomavirus Protein E6 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Human Papillomavirus Protein E6 Revenue Market Share by Country (2015-2020)
Table 36. North America Human Papillomavirus Protein E6 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Human Papillomavirus Protein E6 Sales Market Share by Type (2015-2020)
Table 38. North America Human Papillomavirus Protein E6 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Human Papillomavirus Protein E6 Sales Market Share by Application (2015-2020)
Table 40. Europe Human Papillomavirus Protein E6 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Human Papillomavirus Protein E6 Sales Market Share by Country (2015-2020)
Table 42. Europe Human Papillomavirus Protein E6 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Human Papillomavirus Protein E6 Revenue Market Share by Country (2015-2020)
Table 44. Europe Human Papillomavirus Protein E6 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Human Papillomavirus Protein E6 Sales Market Share by Type (2015-2020)
Table 46. Europe Human Papillomavirus Protein E6 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Human Papillomavirus Protein E6 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Human Papillomavirus Protein E6 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Human Papillomavirus Protein E6 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Human Papillomavirus Protein E6 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Human Papillomavirus Protein E6 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Human Papillomavirus Protein E6 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Human Papillomavirus Protein E6 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Human Papillomavirus Protein E6 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Human Papillomavirus Protein E6 Sales Market Share by Application (2015-2020)
Table 56. Latin America Human Papillomavirus Protein E6 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Human Papillomavirus Protein E6 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Human Papillomavirus Protein E6 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Human Papillomavirus Protein E6 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Human Papillomavirus Protein E6 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Human Papillomavirus Protein E6 Sales Market Share by Type (2015-2020)
Table 62. Latin America Human Papillomavirus Protein E6 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Human Papillomavirus Protein E6 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Human Papillomavirus Protein E6 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Human Papillomavirus Protein E6 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Human Papillomavirus Protein E6 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Human Papillomavirus Protein E6 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Human Papillomavirus Protein E6 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Human Papillomavirus Protein E6 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Human Papillomavirus Protein E6 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Human Papillomavirus Protein E6 Sales Market Share by Application (2015-2020)
Table 72. Rottapharm Biotech Srl Corporation Information
Table 73. Rottapharm Biotech Srl Description and Major Businesses
Table 74. Rottapharm Biotech Srl Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Rottapharm Biotech Srl Product
Table 76. Rottapharm Biotech Srl Recent Development
Table 77. Selecta Biosciences Inc Corporation Information
Table 78. Selecta Biosciences Inc Description and Major Businesses
Table 79. Selecta Biosciences Inc Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Selecta Biosciences Inc Product
Table 81. Selecta Biosciences Inc Recent Development
Table 82. Transgene SA Corporation Information
Table 83. Transgene SA Description and Major Businesses
Table 84. Transgene SA Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Transgene SA Product
Table 86. Transgene SA Recent Development
Table 87. Abion Inc Corporation Information
Table 88. Abion Inc Description and Major Businesses
Table 89. Abion Inc Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Abion Inc Product
Table 91. Abion Inc Recent Development
Table 92. BioNTech AG Corporation Information
Table 93. BioNTech AG Description and Major Businesses
Table 94. BioNTech AG Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. BioNTech AG Product
Table 96. BioNTech AG Recent Development
Table 97. Cancer Research Technology Ltd Corporation Information
Table 98. Cancer Research Technology Ltd Description and Major Businesses
Table 99. Cancer Research Technology Ltd Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Cancer Research Technology Ltd Product
Table 101. Cancer Research Technology Ltd Recent Development
Table 102. Etubics Corp Corporation Information
Table 103. Etubics Corp Description and Major Businesses
Table 104. Etubics Corp Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Etubics Corp Product
Table 106. Etubics Corp Recent Development
Table 107. Genexine Inc Corporation Information
Table 108. Genexine Inc Description and Major Businesses
Table 109. Genexine Inc Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Genexine Inc Product
Table 111. Genexine Inc Recent Development
Table 112. Hookipa Biotech AG Corporation Information
Table 113. Hookipa Biotech AG Description and Major Businesses
Table 114. Hookipa Biotech AG Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Hookipa Biotech AG Product
Table 116. Hookipa Biotech AG Recent Development
Table 117. Inovio Pharmaceuticals Inc Corporation Information
Table 118. Inovio Pharmaceuticals Inc Description and Major Businesses
Table 119. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E6 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Inovio Pharmaceuticals Inc Product
Table 121. Inovio Pharmaceuticals Inc Recent Development
Table 122. MedImmune LLC Corporation Information
Table 123. MedImmune LLC Description and Major Businesses
Table 124. MedImmune LLC Human Papillomavirus Protein E6 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. MedImmune LLC Product
Table 126. MedImmune LLC Recent Development
Table 127. Global Human Papillomavirus Protein E6 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 128. Global Human Papillomavirus Protein E6 Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Human Papillomavirus Protein E6 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Human Papillomavirus Protein E6 Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Human Papillomavirus Protein E6 Sales Forecast by Country (2021-2026) (K Pcs)
Table 132. North America: Human Papillomavirus Protein E6 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Human Papillomavirus Protein E6 Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Europe: Human Papillomavirus Protein E6 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Human Papillomavirus Protein E6 Sales Forecast by Region (2021-2026) (K Pcs)
Table 136. Asia Pacific: Human Papillomavirus Protein E6 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Human Papillomavirus Protein E6 Sales Forecast by Country (2021-2026) (K Pcs)
Table 138. Latin America: Human Papillomavirus Protein E6 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Human Papillomavirus Protein E6 Sales Forecast by Country (2021-2026) (K Pcs)
Table 140. Middle East and Africa: Human Papillomavirus Protein E6 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Human Papillomavirus Protein E6 Players
Table 145. Human Papillomavirus Protein E6 Customers List
Table 146. Human Papillomavirus Protein E6 Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Papillomavirus Protein E6 Product Picture
Figure 2. Global Human Papillomavirus Protein E6 Sales Market Share by Type in 2020 & 2026
Figure 3. ABN-301 Product Picture
Figure 4. BVAC-C Product Picture
Figure 5. ETBX-041 Product Picture
Figure 6. GX-188E Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Papillomavirus Protein E6 Sales Market Share by Application in 2020 & 2026
Figure 9. Cervical Intraepithelial Neoplasia
Figure 10. Lung Cancer
Figure 11. Oropharyngeal Cancer
Figure 12. Others
Figure 13. Human Papillomavirus Protein E6 Report Years Considered
Figure 14. Global Human Papillomavirus Protein E6 Market Size 2015-2026 (US$ Million)
Figure 15. Global Human Papillomavirus Protein E6 Sales 2015-2026 (K Pcs)
Figure 16. Global Human Papillomavirus Protein E6 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Human Papillomavirus Protein E6 Sales Market Share by Region (2015-2020)
Figure 18. Global Human Papillomavirus Protein E6 Sales Market Share by Region in 2019
Figure 19. Global Human Papillomavirus Protein E6 Revenue Market Share by Region (2015-2020)
Figure 20. Global Human Papillomavirus Protein E6 Revenue Market Share by Region in 2019
Figure 21. Global Human Papillomavirus Protein E6 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Human Papillomavirus Protein E6 Revenue in 2019
Figure 23. Human Papillomavirus Protein E6 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Human Papillomavirus Protein E6 Sales Market Share by Type (2015-2020)
Figure 25. Global Human Papillomavirus Protein E6 Sales Market Share by Type in 2019
Figure 26. Global Human Papillomavirus Protein E6 Revenue Market Share by Type (2015-2020)
Figure 27. Global Human Papillomavirus Protein E6 Revenue Market Share by Type in 2019
Figure 28. Global Human Papillomavirus Protein E6 Market Share by Price Range (2015-2020)
Figure 29. Global Human Papillomavirus Protein E6 Sales Market Share by Application (2015-2020)
Figure 30. Global Human Papillomavirus Protein E6 Sales Market Share by Application in 2019
Figure 31. Global Human Papillomavirus Protein E6 Revenue Market Share by Application (2015-2020)
Figure 32. Global Human Papillomavirus Protein E6 Revenue Market Share by Application in 2019
Figure 33. North America Human Papillomavirus Protein E6 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Human Papillomavirus Protein E6 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Human Papillomavirus Protein E6 Sales Market Share by Country in 2019
Figure 36. North America Human Papillomavirus Protein E6 Revenue Market Share by Country in 2019
Figure 37. U.S. Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Human Papillomavirus Protein E6 Market Share by Type in 2019
Figure 42. North America Human Papillomavirus Protein E6 Market Share by Application in 2019
Figure 43. Europe Human Papillomavirus Protein E6 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Human Papillomavirus Protein E6 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Human Papillomavirus Protein E6 Sales Market Share by Country in 2019
Figure 46. Europe Human Papillomavirus Protein E6 Revenue Market Share by Country in 2019
Figure 47. Germany Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Human Papillomavirus Protein E6 Market Share by Type in 2019
Figure 58. Europe Human Papillomavirus Protein E6 Market Share by Application in 2019
Figure 59. Asia Pacific Human Papillomavirus Protein E6 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Human Papillomavirus Protein E6 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Human Papillomavirus Protein E6 Sales Market Share by Region in 2019
Figure 62. Asia Pacific Human Papillomavirus Protein E6 Revenue Market Share by Region in 2019
Figure 63. China Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Human Papillomavirus Protein E6 Market Share by Type in 2019
Figure 86. Asia Pacific Human Papillomavirus Protein E6 Market Share by Application in 2019
Figure 87. Latin America Human Papillomavirus Protein E6 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Human Papillomavirus Protein E6 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Human Papillomavirus Protein E6 Sales Market Share by Country in 2019
Figure 90. Latin America Human Papillomavirus Protein E6 Revenue Market Share by Country in 2019
Figure 91. Mexico Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Human Papillomavirus Protein E6 Market Share by Type in 2019
Figure 98. Latin America Human Papillomavirus Protein E6 Market Share by Application in 2019
Figure 99. Middle East and Africa Human Papillomavirus Protein E6 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Human Papillomavirus Protein E6 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Human Papillomavirus Protein E6 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Human Papillomavirus Protein E6 Revenue Market Share by Country in 2019
Figure 103. Turkey Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Human Papillomavirus Protein E6 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Human Papillomavirus Protein E6 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Human Papillomavirus Protein E6 Market Share by Type in 2019
Figure 110. Middle East and Africa Human Papillomavirus Protein E6 Market Share by Application in 2019
Figure 111. North America Human Papillomavirus Protein E6 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Human Papillomavirus Protein E6 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Human Papillomavirus Protein E6 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Human Papillomavirus Protein E6 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Human Papillomavirus Protein E6 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Human Papillomavirus Protein E6 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Human Papillomavirus Protein E6 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Human Papillomavirus Protein E6 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Human Papillomavirus Protein E6 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Human Papillomavirus Protein E6 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のヒトパピローマウイルスタンパク質E6市場2026:インサイト・予測] (Global Human Papillomavirus Protein E6 Market Insights and Forecast to 2026 / QYR20NV01430)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆